Nuwellis (NUWE) vs Precision Optics (POCI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Precision Optics is the larger company by market cap ($45.3 million vs $1.8 million), about 24.6 times the size. Precision Optics converts more of its revenue into profit, with a net margin of -11.5% versus -211.9%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NUWE | POCI |
|---|---|---|
| Share price | $3.41 | $4.12 |
| Market cap | $1.84M | $45.30M |
| 1-day change | -10.50% | +1.41% |
| YTD return | — | -1.67% |
| 1-year return | — | -10.43% |
| 5-year return | — | -37.86% |
| P/E ratio (TTM) | 0.00 | — |
| Forward P/E | — | 206.00 |
| EPS (TTM) | $3,609.63 | $-0.25 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $8.27M | $31.53M |
| Revenue growth (YoY) | -5.38% | +65.16% |
| Net income (latest FY) | $-17.52M | $-3.63M |
| Gross margin | 61.96% | 17.22% |
| Operating margin | -134.29% | -11.13% |
| Net margin | -211.86% | -11.51% |
| 52-week high | $1,556.10 | $6.15 |
| 52-week low | $2.52 | $3.55 |
| Distance from 52-week high | -99.78% | -33.01% |
| Analyst consensus | — | strong_buy |
| Avg. price target upside | — | +94.17% |
| Average volume | 829.19K | 43.00K |
| Shares outstanding | 540.91K | 10.99M |
| Employees | 38 | 108 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Precision Optics is about 24.6 times larger than Nuwellis by market value ($45.30M vs $1.84M).
- Precision Optics is more profitable, keeping -11.5 cents of every revenue dollar as net income versus -211.9 cents for Nuwellis.
- Precision Optics grew revenue faster in its latest fiscal year (+65.16% vs -5.38%).
About Nuwellis
NUWE stock →Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 38 employees
About Precision Optics
POCI stock →Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 108 employees
NUWE vs POCI FAQ
Which is bigger, Nuwellis or Precision Optics?
Precision Optics (POCI) is larger, with a market capitalization of $45.30M compared with $1.84M for Nuwellis (NUWE).
Are Nuwellis and Precision Optics in the same industry?
Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.